뒤로
Kuros Biosciences AG(CSBTF) 가격
CSBTF 주가 차트
CSBTF 수입
Kuros Biosciences AG
$34.65
-9.62%
$-3.69
종가: Jan 20, 16:00:00 GMT-5
$34.65
0%
$0
애프터마켓: Jan 20, 19:08:46 GMT-5
주요 통계
이전 종가
$38.34
시가
$34.65
일일 범위
$34.65 - $34.65
52주 범위
$19.43 - $42.81
거래량
600
평균 거래량
63
EPS(TTM)
-0.19
배당수익률
--
시가총액
$1.3B
CSBTF란 무엇인가요?
Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. The company is headquartered in Schlieren, Zuerich and currently employs 122 full-time employees. The company went IPO on 2002-10-29. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic diseases, asthma, malignant melanoma and Alzheimer's disease. They are designed to instruct the patient's immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. The firm has built a pipeline of different Immunodrug candidates, of which five are in clinical development. Its Immunodrug candidates are developed both in-house and together with Novartis, Pfizer and Pfizer Animal Health, among others. The firm has two subsidiaries: a wholly-owned Proteome Therapeutics GmbH and minority owned BioSupport AG.